Table 4.
Differential Expression of Pancreatic Genes in B6J and B6N Mouse Substrains in the Normal Pancreas
| Gene name | Gene symbol | EntrezGene ID | Chr | Fold difference B6J vs B6N |
|---|---|---|---|---|
| UDP glucuronosyltransferase 2 family, polypeptide B34 | Ugt2b34 | 100727 | 5 | 3.0 |
| Ectonucleoside triphosphate diphosphohydrolase 4 | Entpd4 | 67464 | 14 | 2.3 |
| Immunoglobulin lambda variable 1 | Iglv1 | 16142 | 16 | −8.0 |
| Complement component 4B (Chido blood group)∗ | C4b | 12268 | 17 | −5.7 |
| Nicotinamide nucleotide transhydrogenase | Nnt | 18115 | 13 | −2.8 |
| Inter alpha-trypsin inhibitor, heavy chain 4∗ | Itih4 | 16427 | 14 | −2.8 |
| WD repeat and FYVE domain containing 1∗ | Wdfy1 | 69368 | 1 | −2.0 |
A transcript was considered to be highly significantly divergently expressed between B6J and B6N substrains if the P value between strains was <0.01 and the average fold change was >2. A minus sign in the fold difference column indicates lower mRNA abundance in B6J versus B6N. Chr, chromosome.
∗
Significantly altered after cerulein treatment in the CP mouse model.